Abstract
The paper analyzes data on kidney cancer incidence and mortality in Russia and Saint-Petersburg, highlights the issues related to the diagnosis and treatment of kidney cancer, depending on the stage of the disease and the age of the patient. The incidence of kidney cancer has been steadily increasing over the last ten years, and this is predominantly related to the advances in imaging technology and because of the growth and aging of the population. In Russia, the kidney cancer incidence is expected to increase rapidly due to increases in proportion of early kidney cancer patients that makes it extremely important to improve the organ-preserving treatment of this disease. Morphological verification must necessarily be done both in patients with metastatic cancer and in patients planning to undergo ablation treatment.
Highlights
The paper analyzes data on kidney cancer incidence and mortality in Russia and Saint-Petersburg, highlights the issues related to the diagnosis and treatment of kidney cancer, depending on the stage of the disease and the age of the patient
The incidence of kidney cancer has been steadily increasing over the last ten years, and this is predominantly related to the advances in imaging technology and because of the growth and aging of the population
In Russia, the kidney cancer incidence is expected to increase rapidly due to increases in proportion of early kidney cancer patients that makes it extremely important to improve the organ-preserving treatment of this disease
Summary
4. Заболеваемость разных возрастных групп больных раком почки обоих полов грубый статистический показатель на 100 тыс. Заболеваемости как в абсолютных цифрах, так и «грубый» статистический показатель отмечается в возрастной группе 60–79 лет, среди этих же пациентов фиксируется выраженный стабильный прирост заболеваемости РП на протяжении последних 25 лет. В России среди пациентов 60–79 лет впервые выявлено 10 067 случаев РП (50,7 % от общего числа больных РП), или 179,3 на 100 тыс. Рост числа больных РП за 5 лет (2007–2012 гг.) наиболее выражен среди лиц пожилого возраста 60–79 лет, прирост составил в абсолютных значениях 20,9 % и по «грубому» статистическому показателю – 14,7 %, что, вероятно, обусловлено увеличением продолжительности жизни населения, все больше людей доживает до онкологического заболевания, в том числе до РП.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
